1998
DOI: 10.1055/s-2008-1065302
|View full text |Cite
|
Sign up to set email alerts
|

Die direkte Epididymovasostomie

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…24,25 Historically, the enzymatic inactivation of beta-lactam antibiotics has been well-studied, 26,27,28 and strategies aimed at combatting this resistance using an adjuvant approach-where the antibiotic is co-administered with a small molecule inhibitor of the inactivating enzyme-have emerged as fundamentally useful tools for the rescue of betalactam antibiotics in the clinic. 29,30,31,32 With the discovery and characterization of 10 tetracycline-inactivating enzymes with varying resistance profiles, 33,34 the development of small molecule inhibitors of tetracycline destructase enzymes stands at the forefront of strategies aimed at combatting the imminent clinical emergence of this resistance mechanism in multi-drug resistant infections. We herein report preliminary findings focused on understanding the factors that influence inhibitor potency and stability en route to the development of viable adjuvant approaches to counter tetracycline resistance by enzymatic inactivation.…”
mentioning
confidence: 99%
“…24,25 Historically, the enzymatic inactivation of beta-lactam antibiotics has been well-studied, 26,27,28 and strategies aimed at combatting this resistance using an adjuvant approach-where the antibiotic is co-administered with a small molecule inhibitor of the inactivating enzyme-have emerged as fundamentally useful tools for the rescue of betalactam antibiotics in the clinic. 29,30,31,32 With the discovery and characterization of 10 tetracycline-inactivating enzymes with varying resistance profiles, 33,34 the development of small molecule inhibitors of tetracycline destructase enzymes stands at the forefront of strategies aimed at combatting the imminent clinical emergence of this resistance mechanism in multi-drug resistant infections. We herein report preliminary findings focused on understanding the factors that influence inhibitor potency and stability en route to the development of viable adjuvant approaches to counter tetracycline resistance by enzymatic inactivation.…”
mentioning
confidence: 99%